Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TSE:L

Loblaw Companies Ltd (L.TO)

60.53
-0.44 (0.72%)
as of Aug 21, 2026, 8:00:00 pm Market Open.
322 watching
0
Investor Insights
star iconAug 23, 2026, 12:00 am

This summary was created by AI, based on 11 opinions in the last 12 months.

Loblaw Companies Ltd, a leading food and drug retailer in Canada, has experienced significant growth, especially following its acquisition of Shoppers Drug Mart. Experts note its strong performance amid food inflation, and the success of its No Frills discount brand has drawn positive attention. However, concerns about overvaluation are prevalent, with many analysts watching for signs of sustainable growth, especially with increasing competition from Walmart and Costco. While some view the company as a solid defensive investment, others are cautious, indicating that current valuations appear stretched compared to historical standards. Analysts provide mixed views on its future performance, recommending investors consider alternatives in the retail space.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Overvalued
review icon
Similar
ATD
BUY
Strong company. Great brand loyalty. More conservative investors may prefer George Weston.
BUY
Reliable earnings stream.
BUY
Good safe haven. 10% off their highs. Prefers Sobeys.
TOP PICK
Track record is tremendous and should continue.
BUY ON WEAKNESS
Prefers owning George Weston as a cheaper way to have access to Loblaws. Buy below $50 if possible.
BUY
A very strong franchise.Good price.
WEAK BUY
Worries about competition.
BUY
Will deliver good earnings/growth in the next 2/3 years.
DON'T BUY
Nervous about what Walmart is doing in the US.
BUY
Defensive stock. Long term outlook is good.
HOLD
Impressive retailing. Good long core holding.
BUY
Good operators. Quality. Good growth.
BUY
Has been weakening a bit because of their earnings. 25 X earnings.
BUY
Good price. Prefers over Sobeys.
DON'T BUY
Expensive.
Showing 616 to 630 of 707 entries